Preprint Article Version 1 This version is not peer-reviewed

Docking Analysis on Mutated Proteins in Cardio-Facio-Cutaneous Syndrome: Amentoflavone E Hypericin Potential Role

Version 1 : Received: 1 September 2024 / Approved: 2 September 2024 / Online: 3 September 2024 (11:32:29 CEST)

How to cite: ferrari, I. Docking Analysis on Mutated Proteins in Cardio-Facio-Cutaneous Syndrome: Amentoflavone E Hypericin Potential Role. Preprints 2024, 2024090140. https://doi.org/10.20944/preprints202409.0140.v1 ferrari, I. Docking Analysis on Mutated Proteins in Cardio-Facio-Cutaneous Syndrome: Amentoflavone E Hypericin Potential Role. Preprints 2024, 2024090140. https://doi.org/10.20944/preprints202409.0140.v1

Abstract

Cardiofaciocutaneous (CFC) syndrome, linked to mutations in genes including KRAS, BRAF, MEK1, and MEK2, leads to dysregulated RAS-MAPK signaling with limited therapeutic options. This study utilized molecular docking simulations to screen natural compounds against mutated KRAS, BRAF, MEK1, and MEK2 structures. Promising candidates such as Amentoflavone and Hypericin displayed strong binding affinities and favorable interactions with mutated sites, suggesting their potential as lead molecules for targeted therapies in CFC syndrome. This research offers novel insights into therapeutic interventions for this rare genetic disorder.

Keywords

Hypericin; Amentoflavone; Docking analysis; Autodock Vina; Cardiofaciocutaneous

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.